Texas Health Resources:企業の戦略的SWOT分析

◆英語タイトル:Texas Health Resources - Strategic SWOT Analysis Review
◆商品コード:DATA904C13809
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Texas Health Resources – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Texas Health Resources (THR) is a nonprofit health care organization that provides healthcare services. It is one of the largest nonprofit healthcare delivery systems operating in the US and also the largest in North Texas in terms of patients served. The organization focuses on providing health and hospice, physical therapy and rehabilitation, heart and vascular, diabetes and cancer services, among others. It offers services through its acute care hospitals, rehabilitation centers, behavioral health hospitals and centers, outpatient and surgery centers. THR operates healthcare facilities in the Dallas Fort Worth and North Texas regions.. It also provides clinical studies management, medical device testing, and medical training services through its Texas Health’s Research and Education Institute. THR is headquartered in Arlington, Texas, the US.

Texas Health Resources Key Recent Developments

Jul 12,2018: Texas Health Resources and Adventist Health System to Build New Health Care Campus in Mansfield, Texas
Jan 02,2018: Joseph DeLeon Named President of Texas Health Fort Worth

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Texas Health Resources – Key Facts
Texas Health Resources – Key Employees
Texas Health Resources – Key Employee Biographies
Texas Health Resources – Major Products and Services
Texas Health Resources – History
Texas Health Resources – Company Statement
Texas Health Resources – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Texas Health Resources – Business Description
Texas Health Resources – SWOT Analysis
SWOT Analysis – Overview
Texas Health Resources – Strengths
Texas Health Resources – Weaknesses
Texas Health Resources – Opportunities
Texas Health Resources – Threats
Texas Health Resources – Key Competitors
Section 3 – Company’s Recent Developments
Jul 12, 2018: Texas Health Resources and Adventist Health System to Build New Health Care Campus in Mansfield, Texas
Jan 02, 2018: Joseph DeLeon Named President of Texas Health Fort Worth
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Texas Health Resources, Key Facts
Texas Health Resources, Key Employees
Texas Health Resources, Key Employee Biographies
Texas Health Resources, Major Products and Services
Texas Health Resources, History
Texas Health Resources, Other Locations
Texas Health Resources, Subsidiaries
Texas Health Resources, Key Competitors

★海外企業調査レポート[Texas Health Resources:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gamida Cell Ltd:企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • CVS Health Corp (CVS):製薬・医療:M&Aディール及び事業提携情報
    Summary CVS Health Corporation (CVS) is an integrated prescription and related health services provider. The company offers a range of solutions such as prescription medications; health care products; popular beauty, health and personal care brands; retail-based health clinical services; and pharmac …
  • Knight-Swift Transportation Holdings Inc (KNX):企業の財務・戦略的SWOT分析
    Knight-Swift Transportation Holdings Inc (KNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Icagen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Icagen Inc (Icagen) (formerly known as XRpro Sciences, Inc.) is a biopharmaceutical company which develops drug candidates to unmet medical needs. The company discovers drug for clinical stage across multiple therapeutics and ion class channel classes. The company provides technologies inclu …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Tellabs, Inc.:企業の戦略的SWOT分析
    Tellabs, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • Curtiss-Wright Corporation (CW)-石油・ガス分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析
    Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company's MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, …
  • Bank of Nanjing Co., Ltd.:戦略・SWOT・企業財務分析
    Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Nanjing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Microbion Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company that develops therapeutic products. The company develops products for the treatment of chronic infections and antibiotic-resistant infections. It develops environmentally responsible solutions to prevent microbial biofi …
  • Toyota Tsusho Corporation (8015):企業の財務・戦略的SWOT分析
    Toyota Tsusho Corporation (8015) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pain Therapeutics, Inc.:企業の戦略・SWOT・財務情報
    Pain Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pain Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • China Southern Airlines Company Limited:戦略・SWOT・企業財務分析
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Syntimmune Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Syntimmune Inc (Syntimmune) is a clinical-stage biotechnology company that focuses to develop Fc receptor (FcRn) based antibody therapeutics for the treatment of autoimmune diseases. Its lead pipeline products includes SYNT001, an investigational humanized IgG4 monoclonal antibody that inhib …
  • US WorldMeds LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary US WorldMeds LLC (US WorldMeds) is a specialty pharmaceutical company that develops, licenses and markets healthcare products to improve lives of patients with challenging conditions and unmet medical needs. The company’s products comprise apokyn, myobloc and revonto. Its apokyn is used for …
  • Maruishi Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Maruishi Pharmaceutical Co Ltd (Maruishi) is a pharmaceutical company that develops and sells medical drugs. The company offers products in the fields of perioperative and infection control. Its products include anesthetics, perioperative drugs, pharmacopoeia drugs, and disinfectants and ant …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆